Literature DB >> 29499325

YAP promotes breast cancer metastasis by repressing growth differentiation factor-15.

Ting Wang1, Beibei Mao2, Chi Cheng3, Zhuangzhi Zou4, Junling Gao1, Yanglu Yang5, Tong Lei1, Xiaolong Qi5, Zengqiang Yuan6, Wentong Xu7, Zhongbing Lu8.   

Abstract

The transcriptional co-activator Yes-associated protein (YAP) has been implicated as an oncogene and is found to promote breast cancer metastasis. However, the pro-metastatic mechanism of YAP remains unclear. Here, we demonstrated that YAP functions as a transcriptional repressor of growth differentiation factor-15 (GDF15), a divergent member of the transforming growth factor superfamily, in several breast cancer cell lines. Functionally, knockdown of YAP decreased, whereas knockdown of GDF15 increased, the metastatic potential of breast cancer cells. More than that, the reduced metastasis in YAP-depleted cells could be reversed by simultaneous knockdown of GDF15. Mechanistically, the repressive effect of YAP on GDF15 requires its transcriptional factor TEAD (TEA domain family). In addition, YAP recruits polycomb repressive complex 2 (PRC2) to tri-methylate histone H3 lysine 27 in the promoter region of GDF15. Co-immunoprecipitation experiments demonstrated that YAP and enhancer of zeste 2 PRC2 subunit (EZH2) physically interact with each other. In conclusion, our data reveal that YAP promotes metastasis of breast cancer cells by repressing GDF15 transcription and present a novel molecular mechanism underlying the pro-metastasis function of YAP oncoprotein, with the implication of a therapeutic avenue for breast cancer treatment.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer metastasis; EZH2; GDF15; YAP

Mesh:

Substances:

Year:  2018        PMID: 29499325     DOI: 10.1016/j.bbadis.2018.02.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  23 in total

Review 1.  Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients.

Authors:  Anna Spanopoulou; Vasiliki Gkretsi
Journal:  Clin Exp Metastasis       Date:  2020-06-05       Impact factor: 5.150

Review 2.  Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases.

Authors:  Seung Joon Baek; Thomas Eling
Journal:  Pharmacol Ther       Date:  2019-02-18       Impact factor: 12.310

Review 3.  Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.

Authors:  Jawed Akhtar Siddiqui; Ramesh Pothuraju; Parvez Khan; Gunjan Sharma; Sakthivel Muniyan; Parthasarathy Seshacharyulu; Maneesh Jain; Mohd Wasim Nasser; Surinder Kumar Batra
Journal:  Cytokine Growth Factor Rev       Date:  2021-11-17       Impact factor: 7.638

4.  Circular RNA circRPPH1 promotes triple-negative breast cancer progression via the miR-556-5p/YAP1 axis.

Authors:  Yehui Zhou; Xiaorong Liu; Jing Lan; Yuqiu Wan; Xun Zhu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

5.  Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer.

Authors:  Xiaoya Zhao; Jianfei Fu; Bin Hu; Lin Chen; Jing Wang; Jinyong Fang; Chenyang Ge; Haiping Lin; Kailing Pan; Liang Fu; Lude Wang; Jinlin Du; Wenxia Xu
Journal:  Front Cell Dev Biol       Date:  2021-05-12

Review 6.  Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.

Authors:  Jörg Wischhusen; Ignacio Melero; Wolf Herman Fridman
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

7.  Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.

Authors:  Jie Shen; Beibei Cao; Yatao Wang; Chenshen Ma; Zhuo Zeng; Liang Liu; Xiaolan Li; Deding Tao; Jianping Gong; Daxing Xie
Journal:  J Exp Clin Cancer Res       Date:  2018-07-28

8.  Inhibition of yes-associated protein suppresses migration, invasion, and metastasis in non-small cell lung cancer in vitro and in vivo.

Authors:  Tomoya Takeda; Masanobu Tsubaki; Shuji Genno; Takuya Matsuda; Yuuta Yamamoto; Akihiro Kimura; Nao Shimizu; Shozo Nishida
Journal:  Clin Exp Med       Date:  2021-07-01       Impact factor: 3.984

9.  The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.

Authors:  Lu Zhao; Shuang Han; Junde Hou; Wenhui Shi; Yonglei Zhao; Yongxue Chen
Journal:  Aging (Albany NY)       Date:  2021-06-14       Impact factor: 5.682

Review 10.  YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

Authors:  Janine S A Warren; Yuxuan Xiao; John M Lamar
Journal:  Cancers (Basel)       Date:  2018-04-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.